Skip to main content

Advertisement

Log in

Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Tumor necrosis factor (TNF)-alpha antagonists successfully modulate the pathogenesis of rheumatoid arthritis (RA). However, little is known about the effect of TNF-alpha blockade on the histology of chronic viral hepatitis. We describe the cases of two patients with RA, one with concurrent chronic hepatitis B virus and the other with hepatitis C virus infection who, as part of their evaluation, underwent liver biopsies while undergoing treatment with a TNF-alpha antagonist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fang JW, Shen WW, Meager A, Lau JY (1996) Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am J Gastroenrol 91(4):748–753

    CAS  Google Scholar 

  2. Kallinowski B, Haseroth K, Marinos G, Hanck C et al (1998) Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 111:269–277

    Article  PubMed  CAS  Google Scholar 

  3. Nelson DR, Lim HL, Marousis CG, Fang JW et al (1997) Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42:2487–2494

    Article  PubMed  CAS  Google Scholar 

  4. Magrin S, Craxi A, Fabiano C et al (1994) Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 19(2):273–279 (Feb)

    Article  PubMed  CAS  Google Scholar 

  5. Ostuni P, Botsios C, Punzi L, Sfriso P et al (2003) Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686–687

    Article  PubMed  CAS  Google Scholar 

  6. Michel M, Duvoux C, Hezode C, Cherqui D (2003) Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still’s disease. J Rheumatol 30(7):1624–1625 (Jul)

    PubMed  Google Scholar 

  7. Oniankitan O, Duvoux C, Challine D, Mallat A et al (2004) Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C. J Rheumatol 31:107–109

    PubMed  CAS  Google Scholar 

  8. Calabrese LH, Zein N, Vassilopoulos D (2004) Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 63(Suppl 2):ii18–ii24

    Google Scholar 

  9. Sakellariou GT, Chatzigiannis I (2007) Long term anti-TNF alpha therapy for ankylosing spondylitis in two patients with chronic HBV infection. Clin Rheumatol 26:950–952

    Article  PubMed  Google Scholar 

  10. Roux C, Brocq O, Breuil V et al (2006) Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology 45:1294–1297

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Primal P. Kaur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaur, P.P., Chan, V.C. & Berney, S.N. Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports. Clin Rheumatol 27, 1069–1071 (2008). https://doi.org/10.1007/s10067-008-0896-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-0896-y

Keywords

Navigation